News
http://www.biocept.com
daily12008-10-22T19:45:11ZBiocept Looking to Redefine CTC Dx Market, Plans Product Launch - 8/30/2010 http://www.biocept.com/news/biocept-looking-to-redefine-ctc-dx-market-plans-product-launch-8-30-2010 Biocept's Go Ahead with Plans to Launch a Viable Product in the Fall, with More to Follow.No publisherlsmith2010-09-03T20:55:42ZNews ItemBiocept Targets Spreading Tumors with Advance in Diagnostics - 8/20/2010 http://www.biocept.com/news/biocept-looking-to-redefine-ctc-dx-market-plans-product-launch-august-30-2010 Biocept, Inc. Pioneers Revolutionary Diagnostics Aimed at Personalized Cancer ManagementNo publisherlsmith2010-09-03T20:47:41ZNews ItemBiocept, Inc. Announces Two New Director Appointments - July 1, 2009 http://www.biocept.com/news/biocept-inc.-announces-two-new-director Biocept, Inc. ("Biocept"), an emerging leader in biotechnology, announced today the appointment of Daniel H. Petree and M. Faye Wilson as Directors.No publishereditor2009-07-08T18:36:04ZNews ItemBiocept Awarded Accreditation by the College of American Pathologists - December 3, 2008 http://www.biocept.com/news/biocept-awarded-accreditation-by-the-college-of Biocept, Inc. ("Biocept"), an emerging leader in biotechnology, announced today their CLIA laboratory has been awarded accreditation by the Commission on Laboratory Accreditation of the College of American Pathologists (CAP), based on the results of a recent on-site inspection. No publishereditor2008-12-04T19:30:44ZNews ItemBiocept, Inc. Announces CEO and Director Appointments - October 6, 2008 http://www.biocept.com/news/biocept-inc.-announces-ceo-and-director Biocept, Inc. ("Biocept"), an emerging leader in biotechnology, announced today the appointment of Stephen M. Coutts, Ph.D. as CEO, President and Director and the appointment of Edward A. Dennis, Ph.D., as Director. Biocept also announced the resignation of its former CEO, President and Director, Gordon F. Janko. No publishereditor2008-10-31T19:32:15ZNews ItemBiocept Announces Study to Isolate Circulating Tumor Cells from Blood - December 3, 2007 http://www.biocept.com/news/isolate-circulating-tumor-cells-from-blood Biocept, an emerging leader in biotechnology, is initiating a collaborative study with the University of Texas M.D. Anderson Cancer Center to investigate the ability to isolate circulating tumor cells (CTCs) in blood. The study will use Biocept's proprietary CEE(TM) (Cell Enrichment and Extraction) technology, designed to capture rare cells from a larger heterogeneous cell population. The focus of this study is ovarian cancer.No publisheradmin2008-10-31T19:33:31ZNews Item